How Adcock was paid
$12.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Richard AdcockPresident and CEO | $831,667 | $141,684 | $2,787,828 | $8,353,406 | $485,166 | $117,202 | $12,716,953 |
| David SachsCFO | $591,711 | $66,974 | $836,347 | $2,506,022 | $229,336 | $14,153 | $4,244,543 |
| Patrick Soon-Shiong, M.D.Global Chief Scientific and Medical Officer | $648,826 | $110,535 | $2,787,828 | $8,353,406 | $378,503 | $14,157 | $12,293,255 |
| Regan LauerChief Accounting Officer | $338,773 | $38,344 | $55,755 | $167,068 | $131,302 | $14,071 | $745,313 |
What changed and why
- $113MFull-year 2025 net product revenue reached $113 million, representing a 700% increase over the prior year.
- $12.7MCEO Richard Adcock received total compensation of $12,716,953 in 2025, compared to $10,954,875 in 2024.
- 3%Base salaries for NEOs increased by 3% to 5% in March 2025.
- 77%Corporate performance goals under the 2025 STIP were achieved at approximately 77% of target.
- 100%Discretionary bonuses were awarded to bring total annual bonus payouts to 100% of target opportunities.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.